Agios Pharmaceuticals Inc (AGIO)
30.46
-0.38
(-1.23%)
USD |
NASDAQ |
Mar 28, 11:35
Agios Pharmaceuticals Enterprise Value: 873.30M for March 27, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Alnylam Pharmaceuticals Inc | 33.42B |
| Bruker Corp | 8.536B |
| Palatin Technologies Inc | 14.79M |
| Blueprint Medicines Corp | 5.506B |
| Organon & Co | 11.96B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -96.52M |
| Revenue (Quarterly) | 10.73M |
| Total Expenses (Quarterly) | 135.77M |
| EPS Diluted (Quarterly) | -1.74 |
| Gross Profit Margin (Quarterly) | 88.26% |
| Profit Margin (Quarterly) | -899.6% |
| Earnings Yield | 37.23% |
| Normalized Earnings Yield | -20.72 |